2022-RA-1171-ESGO Total vaginectomy for recurrent gynecological cancer. Experience in kazior

Alima Satanova, Dilyara Kaydarova, Yerlan Kukubassov, Orynbassar Bertleuov, Dauren Kaldybekov, Raikhan Bolatbekova
2022 Vaginal and vulvar cancer   unpublished
follow-up of 13.5 months, half of the patients had no evidence of disease. Conclusion Our institutional experience comprising intensive clinical and emotional management of vulvar carcinoma radiotherapy provides a proactive approach involving frequent assessment, initiated breaks and emotional support, all facilitating improvement in historically low treatment compliance.
doi:10.1136/ijgc-2022-esgo.957 fatcat:gdqxm2hu5new5a7xcjztybbkay